This content is machine translated When basal cell carcinomas prove difficult to treat Reaching the goal with innovative therapy strategies The further development of patient-oriented, function-preserving treatment strategies is an important concern of skin cancer research. For patients with advanced cutaneous basal cell carcinoma (BCC), there is a need for...…
View Post 4 min This content is machine translated Cholangiocarcinoma Modern molecular diagnostics and targeted therapy options Cholangiocarcinoma (CCA) is one of the most aggressive tumors of the hepatobiliary system and is often only diagnosed at an advanced stage. Advances in molecular diagnostics and targeted therapy are...…
View Post 4 min This content is machine translated HER2+ early breast cancer DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines The phase III DESTINY-Breast11 trial shows that neoadjuvant trastuzumab deruxtecan (T-DXd) could provide an anthracycline-free treatment option for HER2-positive early breast cancer. The results suggest an effective and better tolerated...…
View Post 5 min This content is machine translated Mantle cell lymphoma Recurrence after BTK inhibition – prognostic factors and treatment options Mantle cell lymphoma (MCL) is a rare B-cell non-Hodgkin’s lymphoma with a markedly heterogeneous course. The spectrum ranges from indolent, slowly progressive forms to highly aggressive variants. Diagnosis and treatment...…
View Post 8 min This content is machine translated Urothelial carcinoma Immune and targeted therapy options: Evidence situation 2025/2026 The treatment of urothelial carcinoma has developed significantly in recent years. Modern immunotherapies, antibody-drug conjugates (ADCs) and targeted substances complement conventional chemotherapies and increasingly enable individualized treatment strategies. New data...…
View Post 36 min This content is machine translated Prostate and ovarian cancer Fertility preservation from gonads to genomes to genoids Ovarian and prostate cancers rely on common hormonal, genetic and inflammatory mechanisms that influence both tumor progression and gonadal reproductive function in both sexes; in addition, ovarian stem cell populations...… CME-Test
View Post 14 min This content is machine translated Cardio-oncology When the heart pays for cancer treatment Recent studies show that cardiovascular mortality can become the leading cause of death in cancer survivors over the years. New data on ICI myocarditis, landmark cardioprotection trials and the first...…
View Post 12 min This content is machine translated Prevention and early detection: breast and ovarian cancer Screening strategies, risk genetics and guideline recommendations Breast cancer is the most common cancer in women worldwide – and also the one with the greatest potential for reducing mortality through structured screening. A German long-term study presented...…
View Post 3 min This content is machine translated Neuroendocrine tumors Precision medicine in diagnostics and therapy Thanks to modern imaging and molecular characterization, neuroendocrine tumours can now be detected and classified in a much more targeted manner. New therapeutic procedures such as radioligand therapy and targeted...…
View Post 7 min This content is machine translated H. pylori infection: current study data Fewer gastric carcinomas and peptic ulcers after eradication Despite a worldwide decline in the prevalence of Helicobacter pylori (H. pylori), the infection is still widespread. It is estimated that around one in three people in Europe is colonized...…
View Post 6 min This content is machine translated Head and neck squamous cell carcinoma Precision immunotherapy and local treatment The role of immunotherapy in the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC) is currently being reassessed. At the SOHC Congress 2025 in Basel, Yungan Tao...…
